• Real-world Eligibility for Treatment-Free Remission in Chronic Myeloid Leukaemia Patients-Report from a Tertiary Cancer Centre in India
presented at the International CML Conference-2017 (iCMLf)
• Long-term and short-term outcomes in patients of chronic myeloid leukaemia treated with generic and innovator imatinib- a retrospective analysis
presented at the International CML Conference-2017 (iCMLf)
• Outcomes of Chronic Myeloid Leukemia-Chronic Phase Patients Treated with Generic Imatinib- Report from Tata Memorial Hospital
oral presentation in Annual meeting of Mumbai Hematology Group
March 2018
• Trastuzumab Emtansine in HER2 positive metastatic breast cancer: A real-world experience
E poster in ASCO- 2018
ASCO Abstract #226633
• Chemotherapy-Induced Anemia / Zydus Cadila- Desidustat
Phase 1
Principal Investigator
2021 - Clinical Trial
• Non-small cell lung carcinoma / Pfizer- ICON PLC- Dacomitinib
Phase 4
Principal Investigator
2021- Ongoing Clinical Trial
• Breast / Ovarian / Prostate Cancer (NATCO Pharma / CBCC Global)- Olaparib
BA/BE
Principal Investigator
2021 - Ongoing
• Prostate Cancer/ Pfizer- ICON PLC- Talazoparib
Phase 3
Principal Investigator
2021
• Renal Cell Carcinoma/ Axis Clinicals- Sunitinib
BA/BE
Principal Investigator
2021- Ongoing
• Relapsed multiple myeloma- Carfilzomib- Amgen
Phase 4
Principal Investigator
2021- Ongoing
• SPEAR Registry- Novartis- PIK3CA testing observational
Principal Investigator
2021- Ongoing